Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
Fatemeh Nouri Emamzadeh(Lancaster University), Andrei Surguchov(Veterans Health Administration)
Cited by 569
Related Papers
α-Synuclein Interacts with Lipoproteins in Plasma
|Journal of Molecular Neuroscience|2017|42
Effects of different isoforms of apoE on aggregation of the α‐synuclein protein implicated in Parkinson’s disease
|Neuroscience Letters|2016|39
Effect of γ-Synuclein Silencing on Apoptotic Pathways in Retinal Ganglion Cells
|Journal of Biological Chemistry|2008|33
Association between Parkinson’s Disease and Cancer: New Findings and Possible Mediators
|International Journal of Molecular Sciences|2024|13